![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 13
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 13
Showing 13 citing articles:
A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 42
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 42
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults
Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116353-116353
Open Access | Times Cited: 8
Francesco Samarelli, Rosa Purgatorio, Gianfranco Lopopolo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116353-116353
Open Access | Times Cited: 8
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer’s disease
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108241-108241
Closed Access
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108241-108241
Closed Access
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
Kinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115695-115695
Open Access | Times Cited: 8
Kinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115695-115695
Open Access | Times Cited: 8
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 2
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117829-117829
Open Access | Times Cited: 2
Melatonin and Related Compounds as Antioxidants
Alexia Barbarossa, Antonio Carrieri, Alessia Carocci
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 546-565
Closed Access | Times Cited: 4
Alexia Barbarossa, Antonio Carrieri, Alessia Carocci
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 546-565
Closed Access | Times Cited: 4
Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer’s drugs
Luca Piemontese
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2671-2672
Open Access | Times Cited: 3
Luca Piemontese
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2671-2672
Open Access | Times Cited: 3
Exploring the Pivotal Role of Pyrrolidine Ring in Search of Multipotent Agents in Neurodegenerative Diseases
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
(2024)
Closed Access
Antonio Carrieri, Alexia Barbarossa, Modesto de Candia, et al.
(2024)
Closed Access
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates
Rosalba Leuci, Slobodanka Simic, Antonio Carrieri, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107895-107895
Open Access
Rosalba Leuci, Slobodanka Simic, Antonio Carrieri, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107895-107895
Open Access
Approved Drug Regimens, Combinations, and Delivery Systems for Alzheimer’s Disease
Golamari Siva Reddy, Sreenu Thalla
(2024), pp. 177-198
Closed Access
Golamari Siva Reddy, Sreenu Thalla
(2024), pp. 177-198
Closed Access
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access
The Structural Basis of DL0410, a Novel Multi-Target Candidate Drug for the Treatment of Alzheimer’s Disease
Ailin Liu, Jun Zhao, Nicholas J. Huls, et al.
Crystals (2023) Vol. 14, Iss. 1, pp. 59-59
Open Access | Times Cited: 1
Ailin Liu, Jun Zhao, Nicholas J. Huls, et al.
Crystals (2023) Vol. 14, Iss. 1, pp. 59-59
Open Access | Times Cited: 1